Fabrice Barlesi, Chief Executive Officer at Gustave Roussy, shared a post on LinkedIn by RAISE, adding:
“Major support for research from Gustave Roussy, the 1st cancer center in Europe and the 3rd in the world.
Today’s research is, and increasingly fast, the drugs and strategies of tomorrow for the 450,000 patients diagnosed each year and the 4 to 6 million women and men living with cancer.
Thank you to RAISE for being by our side in such a determined way.”
Qouting RAISE:
“RAISE raises €100M for its second Invest in Medical Research sharing fund.
The RAISE Group announces the first closing of Investir pour la Recherche Médicale (IPRM), its second sharing fund, with a target size of €200 million. The objective is to share 50% of capital gains and 50% of management costs with four major medical research institutions.
This first round brings together AXA, Banque des Territoires, Crédit Agricole Assurances, CARAC and Pierre Fabre Laboratories, driven by a common conviction: private equity can become a structural lever for financing major causes of general interest.
The beneficiaries are four major institutions whose complementarity covers the entire medical research chain, from basic research to clinical innovation:
Gustave Roussy – the first French and European cancer centre and an international reference in oncology.
Institut Pasteur – a world-renowned biomedical research centre.
Institut Imagine – a European centre dedicated to research, care and teaching in genetic diseases.
Fondation pour la Recherche Médicale (FRM) – a major non-profit funder supporting public medical research in France.
By mobilizing private equity mechanisms for research, IPRM intends to make a complementary and sustainable contribution to this collective effort.”
About IPRM
Investir pour la Recherche Médicale is RAISE’s second sharing fund dedicated to medical research, with a target size of €200 million. Its funding model links investment performance with long-term support for four institutions spanning fundamental research through clinical innovation.
For cancer research, the initiative adds another funding pathway for institutions such as Gustave Roussy, supporting the wider goal of accelerating scientific discoveries toward patient care.”
Read more articles about Cancer Research on OncoDaily.
